Verwijs Marinus's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Mar 20, 2024
- Accession no.
- 0001415889-24-008772
- Filed
- Mar 20, 2024
- Trade date
- Mar 19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $138.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Verwijs MarinusCIK 0001916553 | Officer (CHIEF TECHNICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | Common Stock | MOption exerciseAcquired | +5,300 | $14.59 | +$77,327 | 5,300 | Direct | |
| Mar 19, 2024 | Common Stock | SSaleDisposed | −2,536 | $25.68 | −$65,124.48 | 2,764 | Direct | |
| Mar 19, 2024 | Common Stock | SSaleDisposed | −2,764 | $26.46 | −$73,135.44 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | Common Stock | MOption exerciseDisposed | −5,300 | $0.00 | $0 | 84,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.